Clinical Trial Update: Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) [Phase 2]

View source ↗

Summary

Phase II trial of capecitabine for unresectable, metastatic, or advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Aga Khan University | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED